-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Family stock medicine is the first line of defense to protect family health
The 2020-2021 “China Family Standing Medicine Listed Brands” selection is jointly sponsored by Family Doctor Online and the new-generation market monitoring agency.
Classics come from quality, high-quality original research protects patients' lives and health
Merck’s classic hypoglycemic drug, Gehuazhi®, as the original product of metformin, has more than 60 years of clinical experience worldwide and has been on the market for more than 25 years in China.
Diabetes affects more than 460 million people worldwide and is a major global public issue
Merck’s other classic cardiovascular treatment drug, Kangxin®, on the list, has been a highly selective β1 blocker that has been clinically used for 35 years and has benefited 114 countries suffering from hypertension and coronary heart disease.
Focus on unmet medical needs and continue to increase innovation in chronic disease management
The "Report on the Status of Nutrition and Chronic Diseases of Chinese Residents (2020)" shows that the health awareness of Chinese residents is gradually increasing, and the premature mortality rate of major chronic diseases is decreasing year by year, but the base of chronic diseases in China is still expanding, and the prevention and control of chronic diseases is still facing huge challenges
In this regard, Mr.
